TY - JOUR
T1 - Vasopressin stimulates Cl- transport in ascending thin limb of Henle's loop in hamster
AU - Takahashi, Nobuyuki
AU - Kondo, Yoshiaki
AU - Ito, Osamu
AU - Igarashi, Yutaka
AU - Omata, Ken
AU - Abe, Keishi
PY - 1995/4
Y1 - 1995/4
N2 - The effect of arginine vasopressin (AVP) on NaCl transport was investigated in the isolated microperfused hamster ascending thin limb of Henle's loop by measuring transepithelial voltage (Vt) and transmural 22Na+ and 36Cl- fluxes. In the presence of a transmural NaCl concentration gradient (100 mM higher in the lumen), Vt was 8.4±0.4 mV. Addition of 1 nM AVP to the basolateral solution increased Vt to 9.6±0.4 mV, which corresponds to an increase in the Cl- to Na+ permselectivity ratio (P(Cl)/P(Na)) from 2.8±0.2 to 3.4±0.2. AVP at physiological concentrations increased Vt in a dose-dependent manner with an ED50 of 5 pM. AVP increased the Cl- efflux coefficient from 99.6±6.3 to 131.4±10.6 x 10-7 cm2/s without affecting the Na+ efflux coefficient. 5-Nitro-2-(3-phenyl- propylamino)-benzoate (0.2 mM), a Cl- channel inhibitor, in the perfusate decreased the basal Cl- efflux coefficient and inhibited the AVP-induced increase in this parameter. The AVP-induced increase in Vt was not affected by [d(CH2)51,O-Me-Tyr2,Arg8] vasopressin, a V1 receptor antagonist, but was abolished by [d(CH2)5,D-Ile2,Ile4,Arg8] vasopressin, a V2 receptor antagonist. The selective V2 agonist dDAVP in 1 nM also increased Vt from 8.6±0.7 to 9.5±0.6 mV. Dibutyryl cAMP and forskolin both increased Vt, whereas H89, an inhibitor of cAMP-dependent protein kinase, abolished the AVP-induced increase in Vt. These results demonstrate that AVP stimulates Cl- transport in the ascending thin limb of Henle's loop by activating Cl- channels via a signal transduction cascade comprising V2 receptors, adenylate cyclase, and cAMP-dependent protein kinase. The ascending thin limb of Henle's loop thus participates in the formation of concentrated urine as one of the target renal tubular segments of AVP.
AB - The effect of arginine vasopressin (AVP) on NaCl transport was investigated in the isolated microperfused hamster ascending thin limb of Henle's loop by measuring transepithelial voltage (Vt) and transmural 22Na+ and 36Cl- fluxes. In the presence of a transmural NaCl concentration gradient (100 mM higher in the lumen), Vt was 8.4±0.4 mV. Addition of 1 nM AVP to the basolateral solution increased Vt to 9.6±0.4 mV, which corresponds to an increase in the Cl- to Na+ permselectivity ratio (P(Cl)/P(Na)) from 2.8±0.2 to 3.4±0.2. AVP at physiological concentrations increased Vt in a dose-dependent manner with an ED50 of 5 pM. AVP increased the Cl- efflux coefficient from 99.6±6.3 to 131.4±10.6 x 10-7 cm2/s without affecting the Na+ efflux coefficient. 5-Nitro-2-(3-phenyl- propylamino)-benzoate (0.2 mM), a Cl- channel inhibitor, in the perfusate decreased the basal Cl- efflux coefficient and inhibited the AVP-induced increase in this parameter. The AVP-induced increase in Vt was not affected by [d(CH2)51,O-Me-Tyr2,Arg8] vasopressin, a V1 receptor antagonist, but was abolished by [d(CH2)5,D-Ile2,Ile4,Arg8] vasopressin, a V2 receptor antagonist. The selective V2 agonist dDAVP in 1 nM also increased Vt from 8.6±0.7 to 9.5±0.6 mV. Dibutyryl cAMP and forskolin both increased Vt, whereas H89, an inhibitor of cAMP-dependent protein kinase, abolished the AVP-induced increase in Vt. These results demonstrate that AVP stimulates Cl- transport in the ascending thin limb of Henle's loop by activating Cl- channels via a signal transduction cascade comprising V2 receptors, adenylate cyclase, and cAMP-dependent protein kinase. The ascending thin limb of Henle's loop thus participates in the formation of concentrated urine as one of the target renal tubular segments of AVP.
KW - Cl channel
KW - V2 receptor
KW - microperfusion
KW - protein kinase A
KW - renal tubule
UR - http://www.scopus.com/inward/record.url?scp=0028908135&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0028908135&partnerID=8YFLogxK
U2 - 10.1172/JCI117836
DO - 10.1172/JCI117836
M3 - Article
C2 - 7706469
AN - SCOPUS:0028908135
SN - 0021-9738
VL - 95
SP - 1623
EP - 1627
JO - Journal of Clinical Investigation
JF - Journal of Clinical Investigation
IS - 4
ER -